IMPURITIES AVAILABLE FOR 'Baricitinib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Baricitinib. Baricitinib is an orally active small-molecule drug belonging to the class of Janus kinase (JAK) inhibitors. It selectively inhibits JAK1 and JAK2 enzymes, which play a key role in inflammatory and immune signaling pathways. By blocking these kinases, baricitinib reduces the activity of pro-inflammatory cytokines involved in autoimmune diseases. It is primarily used for the treatment of moderate to severe rheumatoid arthritis in patients with inadequate response to other therapies. Baricitinib has also been authorized for certain hospitalized COVID-19 patients to control excessive immune response. The drug is rapidly absorbed after oral administration and shows good bioavailability. It is mainly eliminated through renal excretion, both as unchanged drug and metabolites. Common side effects include infections, elevated liver enzymes, and changes in blood cell counts. Regular monitoring is recommended during therapy to minimize the risk of serious adverse effects. Buy high quality Baricitinib from Omsynth Lifesciences.